Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectPsychedelic Drugs: Global Market Outlook
The report provides an overview of the global psychedelic drugs market. This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends.
Transdermal Patches: Global Markets
The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.
Best Selling Pharmaceutical Drugs in 2021
This report discusses the pharmaceutical industry and its competitive landscape and sales of the top 50 bestselling drugs in 2021, in terms of major player market ranking and top 50 pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends have been well-researched and analyzed in this report.
Drugs of Abuse Testing: Technologies and Global Markets
The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.
Nasal Vaccines: Global Markets and Pipeline Analysis
The global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a compound annual growth rate (CAGR) of 8.2% from 2022 through 2027.
Helicobacter pylori Testing: Global Market Outlook
This report provides a brief general outlook of the global market for Helicobacter pylori testing. The report discusses the current and future strategies of vendors in the H. pylori testing market, which includes various invasive and non-invasive tests used to detect H. pylori. The revenues are broken down by region and have been estimated for the five-year period from 2022 through 2027. The report also present details with respect to Helicobacter pylori testing kits.
Bronchitis Treatments: Global Markets
The global market for bronchitis treatments is estimated to grow from $5.8 billion in 2022 to $6.9 billion in 2027, with a compound annual growth rate (CAGR) of 3.5% for the period of 2022-2027.
Regulatory Intelligence Report for Pharmaceuticals in the U.S.
This report presents an understanding of the regulations and requirements of companies in the U.S., as well as foreign companies or establishments planning to manufacture, distribute or market their pharmaceuticals in the U.S. This report provides a brief about the related regulations for registration of the establishments and pharmaceuticals.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2021
This report discusses exhaustive coverage of the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well researched and analyzed in this report. The study include tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market and the factors that will affect the industry in the coming years.
Pediatric Vaccines: Global Markets
The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.
Head and Neck Cancer Therapeutics: Global Markets
The global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.5% from 2022 through 2027.
Laboratory Automation Systems and Processes: Global Markets and T...
The global market for laboratory automation systems and processes is valued at $11.9 billion in 2021 and is estimated to grow from $12.7 billion in 2022 to $18.7 billion in 2027 with a compound annual growth rate (CAGR) of 7.9% for the period of 2022-2027.
Laboratory Animal Models, 3D Cultures and Organoids: Global Marke...
The global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a compound annual growth rate (CAGR) of 22.2% from 2022 through 2027.
Clinical Infant Nutrition: Global Markets
The global clinical infant nutrition market reached $44.8 billion in 2021 and should reach more than $61.5 billion by 2026, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2021-2026.
Monoclonal Antibodies for Oncology: Global Markets
The global market for monoclonal antibodies in oncology is estimated to grow from $76.2 billion in 2022 to more than $138.1 billion by 2027, with a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2022-2027.
Preclinical Research Outsourcing Services: Global Markets
The global market for preclinical research outsourcing services should grown $5.6 billion in 2021 and should reach more than $8.3 billion in 2026, with a compound annual growth rate (CAGR) of 8.1%.
2021 Pharmaceuticals Research Review
BCC Research Market Report for generic drugs should grow from $411.6 billion in 2020 to $650.3 billion by 2025, at compound annual growth rate (CAGR) of 9.6%
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...
The global market for circulating tumor cells (CTC) diagnostics is estimated to increase from $8.8 billion in 2021 to $15.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2021-2026.
Global Markets for Drug-Device Combinations
The global drug-device combination products market should reach $149 billion by 2026 from $103.5 billion in 2021 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2021 to 2026.
Osteoarthritis Therapeutics: Global Markets
The global osteoarthritis therapeutics market should reach $11.2 billion by 2026 from $7.4 billion in 2021 at a compound annual growth rate (CAGR) of 8.6% for the forecast period of 2021 to 2026.
In Vitro Toxicity Testing: Technologies and Global Markets
The global in vitro toxicity testing market should reach $13.3 billion by 2026 from $9.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
Global Markets for Infectious Disease Treatments
The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.
Global Interventional Oncology Market
The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
Antifungal Drugs: Technologies and Global Markets
The global market for antifungal drugs should grow from $14.5 billion in 2021 to $17.9 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.
Targeted Therapeutics Market
The global market for targeted therapeutics should grow from $100.9 billion in 2021 to $142.6 billion by 2026, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2021-2026.
Choose your License
Ubiquitin Proteasome: Global Markets for Drugs, Research Tools and Diagnostics
This report provides an overview of ubiquitin proteasome, targeting therapeutics, research related products and diagnostics products. It includes the approved drugs which are available on the market and research-based products. The report covers market projections through 2028 and company profiles of the major players.
Drugs and Diagnostics for Hematological Disorders: Global Markets
This report provides an overview of the current and potential global market for hematological disorders and its treatments and testing technologies.